Please login to the form below

Not currently logged in
Email:
Password:

legal action

This page shows the latest legal action news and features for those working in and with pharma, biotech and healthcare.

ABPI bid to overturn NICE’s budget impact rules fails

ABPI bid to overturn NICE’s budget impact rules fails

The Association of the British Pharmaceutical Industry (ABPI) has been fighting a legal action to try to overturn NICE’s introduction of a £20m cost ceiling for new drugs that have ... NHS England said in a statement that the High Court “has

Latest news

  • New EU and US approvals for Humira biosimilars New EU and US approvals for Humira biosimilars

    AbbVie is claiming patent protection for Humira in the US out to 2022 and has already taken legal action to try to keep both Amjevita and Cyltezo off the market. ... Thus far, Amgen has opted not to launch its biosimilar 'at-risk' but is waiting to see

  • UK pharma launches legal challenge to NICE plans UK pharma launches legal challenge to NICE plans

    UK pharma launches legal challenge to NICE plans. Applies for judicial review of budget impact test. ... The ABPI is taking legal action to try and block NICE’s forthcoming additional access hurdle for high-cost medicines.

  • Endo faces industry-first FDA call to pull its opioid painkiller Endo faces industry-first FDA call to pull its opioid painkiller

    This action will protect the public from further potential abuse of this product, ”she added. ... However if the firm doesn’t comply the regulatory agency can take legal action to force it to do so.

  • Activists torpedo Immunomedics deal with Seattle Genetics Activists torpedo Immunomedics deal with Seattle Genetics

    In the face of a legal challenge launched by activist investor group venBio, Immunomedics has now said it will abandon the licensing deal agreed in February - which included a $250m upfront ... The settlement also reimburses venBio for legal expenses

  • Eisai slams Cancer Drugs Fund ‘black hole’ Eisai slams Cancer Drugs Fund ‘black hole’

    Eisai slams Cancer Drugs Fund ‘ black hole’. Will consider legal action to address the ‘ unfair and inequitable situation’ for UK cancer patients. ... Eisai is considering taking legal action due to what the company has described as a 'black hole'

More from news
Approximately 14 fully matching, plus 57 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Article: The Colombia Conundrum

    Challenges. For treatments that fall outside of these schemes, there is an alternative route patients can go down to attempt to access them: legal action, via ‘ recobros’.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics